Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial - Agarwal, Neeraj; Azad, Arun A; Carles, Joan; Fay, André P; Matsubara, Nobuaki; Szczylik, Cezary; De Giorgi, Ugo; Young Joung, Jae; Fong, Peter C C; Voog, Eric; Jones, Robert J; Shore, Neal D; et al. (The lancet, 2025)
Online verfügbar: 16. Juli 2025, Artikelversion: 31. Juli 2025